Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial.

•Apheresis reduces lipoprotein(a) and improves thrombotic and fibrinolytic parameters.•Apheresis prolongs occlusion time, reflecting reduced platelet reactivity.•Apheresis reduces lysis time, reflecting enhanced fibrinolysis.•Apheresis reduces von Willebrand factor and fibrinogen.